A revolutionary blood test designed to detect more than 50 types of cancer has failed to achieve its main goal in a trial ...

The FDA is expected to approve a new kind of blood test that may allow earlier diagnosis and less invasive, more effective ...

Scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) have developed a machine learning tool that can detect and ...

Freenome revealed SimpleScreen Lung and a pioneering combined test enabling eligible patients to undergo screening for both ...

Cold caps, hot baths and a cat: Photographer Jessica Pons documented her cancer journey and how it changed her outlook on ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third quarter 2026 following ...

Personalized Cancer Detection provides flexible approach to cover multiple types of cancer screening in a single blood draw – – In an independent cohort, SimpleScreen Lung showed 85% sensitivity at 50 ...

The World Health Organization (WHO) and South Korea’s Ministry of Health and Welfare announced the “AI (Artificial ...

Guardant Health's Shield blood test achieved 99% real-world adherence in two rural clinics, far exceeding typical 28-71% ...

Guardant Health’s oncology portfolio and Shield continue to help with its ongoing growth. It remains exposed to patent ...

You have heard from someone important about how busy they have been or about an event that did not go well. You want to be of help, but you are hesitant because you worry that the more you say, the ...

Guardant Health reported new data from its Shield blood-based colorectal cancer screening test, including modeling and rural clinic results, indicating very high real world adherence and meaningful ...